Real-time Syndromic Surveillance Team, Field Service, National Infection Service, Public Health England, Birmingham, United Kingdom.
Farr Institute at HeRC, University of Liverpool, Liverpool, United Kingdom.
PLoS One. 2020 Oct 8;15(10):e0240021. doi: 10.1371/journal.pone.0240021. eCollection 2020.
Rotavirus infection is a common cause of gastroenteritis in children worldwide, with a high mortality burden in developing countries, particularly during the first two years of life. Rotavirus vaccination was introduced into the United Kingdom childhood vaccination schedule in July 2013, with high coverage (>90%) achieved by June 2016. We used an emergency department (ED) syndromic surveillance system to assess the impact of the rotavirus vaccination programme, specifically through the demonstration of any immediate and continuing impact on ED gastroenteritis visits in England.
This retrospective, observational study used syndromic surveillance data collected from 3 EDs in the two years before (July 2011-June 2013) and 3 years post (July 2013-June 2016) introduction of rotavirus vaccination. The weekly levels of ED visits for gastroenteritis (by age group and in total) during the period before rotavirus vaccination was first described alongside the findings of laboratory surveillance of rotavirus during the same period. An interrupted time-series analysis was then performed to demonstrate the impact of rotavirus vaccination introduction on gastroenteritis ED visit levels.
During the two years before vaccine introduction ED visits for gastroenteritis in total and for the 0-4 years age group were seen to rise and fall in line with the seasonal rotavirus increases reported by laboratory surveillance. ED gastroenteritis visits by young children were lower in the three years following introduction of rotavirus vaccination (reduced from 8% of visits to 6% of visits). These attendance levels in young children (0-4years) remained higher than in older age groups, however the previously large seasonal increases in children were greatly reduced, from peaks of 16% to 3-10% of ED visits per week.
ED syndromic surveillance demonstrated a reduction in gastroenteritis visits following rotavirus vaccine introduction. This work establishes ED syndromic surveillance as a platform for rapid impact assessment of future vaccine programmes.
轮状病毒感染是全球儿童中常见的肠胃炎病因,在发展中国家造成了沉重的死亡率负担,尤其是在生命的头两年。轮状病毒疫苗于 2013 年 7 月被纳入英国儿童免疫接种计划,到 2016 年 6 月,覆盖率达到了 90%以上。我们使用急诊部(ED)症状监测系统来评估轮状病毒疫苗接种计划的影响,特别是通过展示该计划对英格兰 ED 肠胃炎就诊的即时和持续影响。
这是一项回顾性、观察性研究,使用了轮状病毒疫苗接种前两年(2011 年 7 月至 2013 年 6 月)和接种后三年(2013 年 7 月至 2016 年 6 月)期间从 3 家 ED 收集的症状监测数据。在首次描述轮状病毒疫苗接种之前的时间段内,每周 ED 肠胃炎就诊的年龄组和总数,以及同期轮状病毒实验室监测的结果。然后进行了一个中断时间序列分析,以展示轮状病毒疫苗接种引入对肠胃炎 ED 就诊水平的影响。
在疫苗接种前两年,总的 ED 肠胃炎就诊人数以及 0-4 岁年龄组的就诊人数与实验室监测报告的轮状病毒季节性增加呈上升和下降趋势。轮状病毒疫苗接种引入后的三年中,幼儿的 ED 肠胃炎就诊人数较低(从就诊人数的 8%减少到 6%)。然而,与其他年龄组相比,这些幼儿(0-4 岁)的就诊率仍然较高,但是以前儿童中较大的季节性增加大大减少,从每周就诊人数的 16%高峰减少到 3-10%。
ED 症状监测显示轮状病毒疫苗接种后肠胃炎就诊人数减少。这项工作确立了 ED 症状监测作为未来疫苗计划快速影响评估的平台。